{"id":247036,"date":"2025-09-22T19:31:11","date_gmt":"2025-09-22T19:31:11","guid":{"rendered":"https:\/\/www.europesays.com\/us\/247036\/"},"modified":"2025-09-22T19:31:11","modified_gmt":"2025-09-22T19:31:11","slug":"new-hope-for-prostate-cancer-patients-through-the-testing-of-specific-genes-in-their-blood","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/247036\/","title":{"rendered":"New hope for prostate cancer patients through the testing of specific genes in their blood"},"content":{"rendered":"

\t\t\t\t\t\t\t\t\t\"\"
\n\t\t\t\t\t\t\t\t\tSeta Derderian, Simone Chevalier, Armen Aprikian<\/p>\n

Research team at The Institute identifies gene expression signature to help guide treatment decisions for prostate cancer patients<\/strong><\/p>\n

A team led by Simone Chevalier, PhD<\/a> and Armen Aprikian, MD<\/a> at the Research Institute of the McGill University Health Centre (The Institute) has developed a promising approach\u2014recently published in the journal Molecular Oncology<\/a>\u2014that offers a new way to determine how aggressively prostate cancer may behave. By analyzing specific genes in blood RNA, the team has identified distinct expression patterns that could help clinicians predict which patients are at higher risk of progression.<\/p>\n

\u201cThis work represents a major step toward less invasive, more precise tools for identifying aggressive prostate cancer,\u201d said Prof. Chevalier, a senior scientist in the Cancer Research Program<\/a> at The Institute. \u201cThe ultimate goal is to offer more personalized treatments and target high-risk disease earlier.\u201d<\/p>\n

Read more<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Seta Derderian, Simone Chevalier, Armen Aprikian Research team at The Institute identifies gene expression signature to help guide…\n","protected":false},"author":3,"featured_media":247037,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26],"tags":[815,159,67,132,68],"class_list":{"0":"post-247036","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-genetics","8":"tag-genetics","9":"tag-science","10":"tag-united-states","11":"tag-unitedstates","12":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115249616456475146","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/247036","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=247036"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/247036\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/247037"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=247036"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=247036"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=247036"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}